Logo image of ALDUB.PA

ENCRES DUBUIT (ALDUB.PA) Stock Fundamental Analysis

EPA:ALDUB - FR0004030708 - Common Stock

2.2 EUR
-0.14 (-5.98%)
Last: 9/1/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALDUB gets a fundamental rating of 3 out of 10. We evaluated ALDUB against 68 industry peers in the Chemicals industry. The financial health of ALDUB is average, but there are quite some concerns on its profitability. ALDUB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALDUB has reported negative net income.
ALDUB had a negative operating cash flow in the past year.
ALDUB had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALDUB reported negative operating cash flow in multiple years.
ALDUB.PA Yearly Net Income VS EBIT VS OCF VS FCFALDUB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

ALDUB has a Return On Assets of -4.89%. This is in the lower half of the industry: ALDUB underperforms 72.06% of its industry peers.
The Return On Equity of ALDUB (-6.18%) is worse than 69.12% of its industry peers.
Industry RankSector Rank
ROA -4.89%
ROE -6.18%
ROIC N/A
ROA(3y)-4.81%
ROA(5y)-2.69%
ROE(3y)-5.98%
ROE(5y)-3.33%
ROIC(3y)N/A
ROIC(5y)N/A
ALDUB.PA Yearly ROA, ROE, ROICALDUB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

Looking at the Gross Margin, with a value of 36.77%, ALDUB is in line with its industry, outperforming 55.88% of the companies in the same industry.
ALDUB's Gross Margin has been stable in the last couple of years.
ALDUB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.04%
GM growth 5Y0.17%
ALDUB.PA Yearly Profit, Operating, Gross MarginsALDUB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

ALDUB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALDUB has about the same amount of shares outstanding.
The number of shares outstanding for ALDUB has been reduced compared to 5 years ago.
ALDUB has a better debt/assets ratio than last year.
ALDUB.PA Yearly Shares OutstandingALDUB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALDUB.PA Yearly Total Debt VS Total AssetsALDUB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ALDUB has an Altman-Z score of 2.77. This is not the best score and indicates that ALDUB is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.77, ALDUB is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that ALDUB is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.04, ALDUB belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2.77
ROIC/WACCN/A
WACC7.27%
ALDUB.PA Yearly LT Debt VS Equity VS FCFALDUB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 3.87 indicates that ALDUB has no problem at all paying its short term obligations.
The Current ratio of ALDUB (3.87) is better than 94.12% of its industry peers.
ALDUB has a Quick Ratio of 2.72. This indicates that ALDUB is financially healthy and has no problem in meeting its short term obligations.
ALDUB has a better Quick ratio (2.72) than 91.18% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 2.72
ALDUB.PA Yearly Current Assets VS Current LiabilitesALDUB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.03% over the past year.
The Revenue has been growing slightly by 1.26% in the past year.
Measured over the past years, ALDUB shows a decrease in Revenue. The Revenue has been decreasing by -3.06% on average per year.
EPS 1Y (TTM)47.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.47%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y-0.81%
Revenue growth 5Y-3.06%
Sales Q2Q%-2.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-22.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.59%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALDUB.PA Yearly Revenue VS EstimatesALDUB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ALDUB.PA Yearly EPS VS EstimatesALDUB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALDUB. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 21.27, the valuation of ALDUB can be described as rather expensive.
ALDUB's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.76. ALDUB is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 21.27
ALDUB.PA Price Earnings VS Forward Price EarningsALDUB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALDUB.PA Per share dataALDUB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

ALDUB has a Yearly Dividend Yield of 8.98%, which is a nice return.
Compared to an average industry Dividend Yield of 3.08, ALDUB pays a better dividend. On top of this ALDUB pays more dividend than 100.00% of the companies listed in the same industry.
ALDUB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 8.98%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALDUB.PA Yearly Dividends per shareALDUB.PA Yearly Dividends per shareYearly Dividends per share 2023 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALDUB.PA Yearly Income VS Free CF VS DividendALDUB.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

More info and screens

ENCRES DUBUIT

EPA:ALDUB (9/1/2025, 7:00:00 PM)

2.2

-0.14 (-5.98%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)06-04 2024-06-04/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.07%
Ins Owner ChangeN/A
Market Cap6.91M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.98%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.27
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)0.1
Fwd EY4.7%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS6.43
BVpS6.15
TBVpS5.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.89%
ROE -6.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.77%
FCFM N/A
ROA(3y)-4.81%
ROA(5y)-2.69%
ROE(3y)-5.98%
ROE(5y)-3.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.04%
GM growth 5Y0.17%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.75%
Cap/Sales 4.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.87
Quick Ratio 2.72
Altman-Z 2.77
F-Score4
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)67.54%
Cap/Depr(5y)66%
Cap/Sales(3y)3.9%
Cap/Sales(5y)3.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.47%
EPS Next Y-22.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.26%
Revenue growth 3Y-0.81%
Revenue growth 5Y-3.06%
Sales Q2Q%-2.96%
Revenue Next Year-10.59%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.06%
OCF growth 3YN/A
OCF growth 5YN/A